Evidence map›Paper›PMID 29378713›Full record

ArticleAntimicrobial agents and chemotherapy2018

Enhanced Ex Vivo Plasmodium vivax Intraerythrocytic Enrichment and Maturation for Rapid and Sensitive Parasite Growth Assays.

Gabriel W Rangel, Martha A Clark, Usheer Kanjee, Caeul Lim, Kathryn Shaw-Saliba, Maria José Menezes, Anjali Mascarenhas, Laura Chery, Edwin Gomes, Pradipsinh K Rathod and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 1 pooled it
6.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. MaRNAV-1, an intracellular virus ofbioRxiv : the preprint server for biology · 2026
    Article
  5. Article
  6. First Evidence of Anti-Biomedicines · 2025
    Article
  7. Article
  8. The essential genome ofScience (New York, N.Y.) · 2025
    Article
  9. The reticulocyte restriction: invasion ligand RBP1a ofFrontiers in cellular and infection microbiology · 2025
    Article
  10. Article
  11. Article
  12. A Drug Repurposing Approach Reveals Targetable Epigenetic Pathways inbioRxiv : the preprint server for biology · 2024
    Article
  13. Frontiers in cellular and infection microbiology · 2024
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. ACS infectious diseases · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 3 countries.

Gabriel W RangelDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.ORCID 0000-0002-8208-2817
Martha A ClarkDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Usheer KanjeeDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Caeul LimDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Kathryn Shaw-SalibaDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
Maria José MenezesDepartment of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Anjali MascarenhasDepartment of Medicine, Goa Medical College and Hospital, Bambolim, Goa, India.
Laura CheryDepartment of Chemistry, University of Washington, Seattle, Washington, USA.
Edwin GomesDepartment of Medicine, Goa Medical College and Hospital, Bambolim, Goa, India.
Pradipsinh K RathodDepartment of Chemistry, University of Washington, Seattle, Washington, USA.
Marcelo U FerreiraDepartment of Parasitology, Institute of Biomedical Sciences, University of São Paulo, São Paulo, Brazil.
Manoj T DuraisinghDepartment of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA mdruaisi@hsph.harvard.edu.
Harvard University · USUniversity of Washington · USUniversidade de São Paulo · BRGoa Medical College · IN

Funding

Shared TechnologyU19AI089688 · NIAID · UNIVERSITY OF WASHINGTON · PI RATHOD, PRADIPSINH K. · 2010 to 2023
$22.4M
NIAID NIH HHS U19 AI089688
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AntimalarialsBrazilChloroquineHumansIndiaParasitic Sensitivity TestsPlasmodium vivaxAntimalarialsChloroquineantimalarial agentsantimalarialschloroquinemalariaPlasmodium vivax

Identifiers

PMID29378713
PMCPMC5913983
OpenAlexW2793932483

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.